Erich Tauber

Title: Erich Tauber: Innovator in Vaccine Development

Introduction

Erich Tauber is a notable inventor based in Muckendorf, Austria. He has made significant contributions to the field of vaccine development, particularly in relation to Zika virus and purification strategies for viruses. With a total of 2 patents, his work is recognized for its potential impact on public health.

Latest Patents

Tauber's latest patents include innovative approaches to creating recombinant Zika vaccines. The first patent focuses on immunogenic compositions that comprise recombinant Zika virus antigens, specifically targeting the E-protein of the virus. This invention aims to provide effective vaccine compositions that can elicit a strong immune response. The second patent outlines chromatography-based purification strategies for large and pleomorphic infectious virus particles, particularly those derived from a measles virus scaffold. This method significantly reduces the content of contaminating host cell DNA, making it suitable for immunogenic or anti-tumor applications.

Career Highlights

Erich Tauber is currently associated with Themis Bioscience GmbH, where he continues to advance his research in vaccine development. His work is characterized by a commitment to improving the efficacy and safety of vaccines, which is crucial in combating infectious diseases.

Collaborations

Throughout his career, Tauber has collaborated with notable colleagues, including Matthias Müllner and Patrick Csar. These partnerships have fostered a collaborative environment that enhances the innovation process in vaccine research.

Conclusion

Erich Tauber's contributions to vaccine development, particularly through his patents on Zika virus vaccines and purification strategies, highlight his role as a key innovator in the field. His ongoing work at Themis Bioscience GmbH continues to pave the way for advancements in immunization and public health.